Meta-analysis finds lower bleeding risk with apixaban and rivaroxaban vs VKAs in dialysis patients with AF
New Blood Thinners Cut Bleeding Risk For Dialysis Patients
This meta-analysis of observational studies and RCTs compared apixaban or rivaroxaban with vitamin K antagonists in dialysis patients with a…
New blood thinners could save lives for dialysis patients by cutting bleeding and stroke risks while waiting for bigger studies to confirm t…
DOACs versus VKAs for left ventricular thrombus management in adults
Newer Blood Thinners May Be Safer for Heart Clot Patients
A meta-analysis suggests DOACs may be a reasonable alternative to VKAs for left ventricular thrombus, with similar efficacy and potentially …
If you have a blood clot in your heart, newer blood thinners may be just as effective as warfarin with a lower risk of dangerous bleeding.
Case report review of clindamycin use in a 62-year-old male with Neurofibromatosis type 1 and hematoma
A Rare Bleeding Complication Every NF1 Patient Should Know About
This case report review describes the management of a 62-year-old male with Neurofibromatosis type 1 who presented with a hematoma. The pati…
A sudden pain or unexplained lump in someone with NF1 could signal a life-threatening bleed that needs emergency care right away.
FDA approves ticagrelor for multiple indications in cardiology and neurology
Brilinta Now Approved for Stroke Prevention in Three Key Groups
The FDA approved ticagrelor (Brilinta) for patients with ACS, CAD at high risk, and acute ischemic stroke or high-risk TIA. In ACS, it was s…
A widely used heart medication now has FDA approval to prevent first strokes in people with diabetes and to protect against repeat strokes a…
UK Biobank guideline review links higher UMOD levels to lower aortic regurgitation progression risk
Higher UMOD levels linked to lower risk of needing aortic valve replacement surgery in patients with aortic regurgitation
This observational cohort study from the UK Biobank evaluates circulating UMOD levels as a biomarker for aortic regurgitation progression. A…
New data shows people with higher UMOD levels face a lower chance of needing aortic valve surgery. This finding helps doctors better underst…
FDA Approves Sdamlo (amlodipine) for Hypertension and Coronary Artery Disease
FDA approves new blood pressure and heart drug Sdamlo for adults and children.
FDA approved Sdamlo, a calcium channel blocker, for hypertension in adults and children aged 6 years and older, and for coronary artery dise…
The FDA approved Sdamlo (amlodipine) for high blood pressure in adults and children 6 and older, and for certain types of chest pain and hea…
Meta-analysis finds SGLT2 inhibitors reduce cardiac arrest risk in CKD patients
SGLT2 Inhibitors Lower Cardiac Arrest Risk in Kidney Disease
This meta-analysis of 8 RCTs evaluated SGLT2 inhibitors versus placebo in patients with chronic kidney disease. SGLT2i significantly reduced…
A meta-analysis of 8 trials found SGLT2 inhibitors cut cardiac arrest risk by 47% in chronic kidney disease patients, though other arrhythmi…
Systematic review and meta-analysis finds no mortality benefit for alternative loop diuretics in chronic heart failure
Alternative heart failure diuretics show no mortality benefit but higher risk
This meta-analysis of 23 RCTs with 4902 patients with chronic heart failure found that alternative loop diuretics did not reduce all-cause m…
A review of 23 trials found alternative diuretics did not lower death risk in heart failure patients, but some raised safety concerns.
RAS inhibitor use after TAVI linked to lower mortality in severe aortic stenosis
Common Heart Pill May Boost Survival After Valve Replacement
This systematic review and meta-analysis of observational data from 36,015 patients with severe aortic stenosis undergoing TAVI found that u…
A common class of blood pressure pills appears to help people live longer after minimally invasive heart valve replacement, but doctors stil…
LAAC and DOACs match warfarin for stroke prevention in AF patients
LAAC and DOACs Cut Bleeding Risk Better Than Warfarin
A network meta-analysis of 78,594 AF patients found LAAC and DOACs offered similar protection against ischemic stroke as warfarin, while sig…
New research shows two new options for atrial fibrillation patients lower bleeding risks while keeping stroke protection the same as older d…
Health and Wellness coaching for blood pressure control in minor stroke or TIA
Your Daily Habits Could Shield You From Another Stroke
This is a Phase III randomized controlled trial protocol for adults with minor stroke or transient ischaemic attack in New Zealand. The stud…
• Lifestyle coaching cuts blood pressure better than standard care.
Review discusses digital twin architecture for predicting aortic disease progression versus static thresholds
Digital Twins Predict Aortic Aneurysm Growth Before It Becomes Dangerous
This review examines the potential of patient-specific digital twin architecture for managing patients with aortic disease. The authors cont…
A new digital twin model predicts how your aortic aneurysm will grow, helping doctors time treatment earlier and more precisely.